System Prompt:
You are a financial expert tasked with analyzing the impact of a company's historical performance metrics on its stock price change (in percentage). These metrics include Revenue, Earnings Per Share (EPS), and Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), among others. Based on the factors and following guidance ,analyzing the financial reports from the most recently published two quarters and predict the price change (in percentage) after the release of the upcoming financial report. Additionally, an important factor influencing the stock price post-earnings report is the company's guidance among the earnings release.
How this factor influences the stock price:
1.Consistently Exceeding Expectations: If these indicators consistently exceed analysts' expectations, the stock price is more likely to rise. If they fall short of expectations, the stock price is more likely to decline.
2.Growth Trends: If these indicators show positive growth, this indicates strong company performance, and the stock price may rise. Conversely, negative growth suggests weak performance, potentially leading to a drop in stock price.
3.Rate of Change : Accelerated growth in these indicators may amplify stock price increases.Faster declines may intensify stock price drops.
4.Valuation Reasonableness: Evaluate whether the company's valuation is reasonable by examining its Price-to-Earnings (P/E) ratio and Price-to-Sales (P/S) ratio over the past six months. A higher-than-average P/E or P/S may suggest overvaluation. However, if these ratios have been steadily increasing—indicating that the current price is much higher than the historical average—it could still be justified if the industry or the stock itself is experiencing major positive shifts or tailwinds.
5.Guidance Above Expectations: If the guidance for the upcoming earnings report exceeds analysts' expectations, the stock price is likely to rise post-earnings release. Therefore, assess whether the upcoming earnings guidance can exceed analysts' expectations based on the financial performance of the last two quarters and recent industry news to predict the stock price post-earnings report.Additionally, search the internet for news from the past two months to evaluate whether the news is positive or negative, and use this to further assess the likelihood of exceeding guidance expectations. For example:Positive News: If the news indicates industry trends such as supply shortages or surging demand, the likelihood of the company raising its guidance and exceeding analysts' expectations increases.Negative News: Conversely, if the news reports industry oversupply, price wars, new competitors entering the market, or shortages in upstream raw materials, the likelihood of the company's guidance falling short of analysts' expectations increases.By combining the analysis of financial data and industry news, please assess whether the company's guidance to be announced during the upcoming earnings call will exceed analysts' expectations.

User Prompt:
The company name is GeneDx Holdings Corp. Class A Common Stock.
The company's symbol is WGS.
The company's overview is
GeneDx Holdings Corp is a company operating in the health technology sector, specifically within the genomic testing industry. The company recently made headlines with its acquisition of Fabric Genomics, which aims to enhance its testing capabilities using decentralized AI technologies at a global scale. This strategic move is anticipated to significantly broaden GeneDx's market reach and positively impact its stock price.

In terms of business details, GeneDx generates its revenue primarily from innovative genomic testing services, including exome and genome testing. The company has been recognized among high-growth stocks, indicating strong revenue growth potential compared to competitors in the health tech sector. Furthermore, its recent partnerships are set to enhance its commercial capabilities in the genomic landscape, which likely bolsters its market position.

Competitively, GeneDx exhibits higher growth rates relative to its peers, suggesting superior competitiveness. The company’s growth in the exome and genome testing market reflects positively on its financial outlook, with expectations of increasing market share. Through strategic partnerships, GeneDx is working to solidify its standing and ensure robust revenues in the future. Overall, these factors create a promising scenario for the stock price post-earnings..

The company's historical performance metrics are
                                                              2024-12-31    2025-03-31
Tax Effect Of Unusual Items                                    -415800.0     -440000.0
Tax Rate For Calcs                                                  0.21           0.4
Normalized EBITDA                                             16344000.0     1336000.0
Total Unusual Items                                           -1980000.0    -1100000.0
Total Unusual Items Excluding Goodwill                        -1980000.0    -1100000.0
Net Income From Continuing Operation Net Minority Interest     5438000.0    -6529000.0
Reconciled Depreciation                                        5558000.0     5678000.0
Reconciled Cost Of Revenue                                    29435000.0    28639000.0
EBITDA                                                        14364000.0      236000.0
EBIT                                                           8806000.0    -5442000.0
Net Interest Income                                            -698000.0     -640000.0
Interest Expense                                                     NaN      640000.0
Normalized Income                                              7002200.0    -5869000.0
Net Income From Continuing And Discontinued Operation          5438000.0    -6529000.0
Total Expenses                                                86834000.0    91666000.0
Total Operating Income As Reported                             8806000.0    -4551000.0
Diluted Average Shares                                               NaN    28147948.0
Basic Average Shares                                                 NaN    28147948.0
Diluted EPS                                                          NaN         -0.23
Basic EPS                                                            0.3          0.91
Diluted NI Availto Com Stockholders                            5438000.0    -6529000.0
Net Income Common Stockholders                                 5438000.0    -6529000.0
Net Income                                                     5438000.0    -6529000.0
Net Income Including Noncontrolling Interests                  5438000.0    -6529000.0
Net Income Continuous Operations                               5438000.0    -6529000.0
Tax Provision                                                   -24000.0      447000.0
Pretax Income                                                  5414000.0    -6082000.0
Other Income Expense                                          -2694000.0     -891000.0
Other Non Operating Income Expenses                            -714000.0      209000.0
Special Income Charges                                               0.0           NaN
Write Off                                                            0.0           NaN
Gain On Sale Of Security                                      -1980000.0    -1100000.0
Net Non Operating Interest Income Expense                      -698000.0     -640000.0
Total Other Finance Cost                                        698000.0           NaN
Interest Expense Non Operating                                       NaN      640000.0
Operating Income                                               8806000.0    -4551000.0
Operating Expense                                             57399000.0    63027000.0
Other Operating Expenses                                        785000.0           NaN
Research And Development                                      11588000.0    12577000.0
Selling General And Administration                            45026000.0    50450000.0
Selling And Marketing Expense                                 17676000.0    18316000.0
General And Administrative Expense                            27350000.0    32134000.0
Other Gand A                                                  27350000.0    32134000.0
Gross Profit                                                  66205000.0    58476000.0
Cost Of Revenue                                               29435000.0    28639000.0
Total Revenue                                                 95640000.0    87115000.0
Operating Revenue                                             94196000.0    85759000.0
Ordinary Shares Number                                        28016545.0    28531642.0
Share Issued                                                  28016545.0    28531642.0
Total Debt                                                   116168000.0   114836000.0
Tangible Book Value                                           86647000.0   102311000.0
Invested Capital                                             297160000.0   309199000.0
Working Capital                                              143151000.0   156275000.0
Net Tangible Assets                                           86647000.0   102311000.0
Capital Lease Obligations                                     64255000.0    63042000.0
Common Stock Equity                                          245247000.0   257405000.0
Total Capitalization                                         297160000.0   309199000.0
Total Equity Gross Minority Interest                         245247000.0   257405000.0
Stockholders Equity                                          245247000.0   257405000.0
Gains Losses Not Affecting Retained Earnings                    830000.0      905000.0
Other Equity Adjustments                                        830000.0      905000.0
Retained Earnings                                          -1352474000.0 -1359003000.0
Additional Paid In Capital                                  1596889000.0  1615501000.0
Capital Stock                                                     2000.0        2000.0
Common Stock                                                      2000.0        2000.0
Preferred Stock                                                      0.0           0.0
Total Liabilities Net Minority Interest                      174133000.0   189025000.0
Total Non Current Liabilities Net Minority Interest          119316000.0   119484000.0
Derivative Product Liabilities                                 3519000.0     4619000.0
Non Current Deferred Liabilities                                965000.0     1153000.0
Non Current Deferred Taxes Liabilities                          965000.0     1153000.0
Long Term Debt And Capital Lease Obligation                  112832000.0   111712000.0
Long Term Capital Lease Obligation                            60919000.0    59918000.0
Long Term Debt                                                51913000.0    51794000.0
Long Term Provisions                                           2000000.0     2000000.0
Current Liabilities                                           54817000.0    69541000.0
Other Current Liabilities                                      2843000.0     6040000.0
Current Debt And Capital Lease Obligation                      3336000.0     3124000.0
Current Capital Lease Obligation                               3336000.0     3124000.0
Current Debt                                                         NaN           NaN
Other Current Borrowings                                             NaN           NaN
Pensionand Other Post Retirement Benefit Plans Current        16987000.0    15634000.0
Current Provisions                                            10586000.0    11981000.0
Payables And Accrued Expenses                                 21065000.0    32762000.0
Current Accrued Expenses                                      11504000.0    14025000.0
Payables                                                       9561000.0    18737000.0
Dueto Related Parties Current                                  1607000.0     2881000.0
Accounts Payable                                               7954000.0    15856000.0
Total Assets                                                 419380000.0   446430000.0
Total Non Current Assets                                     221412000.0   220614000.0
Other Non Current Assets                                       4306000.0     4254000.0
Goodwill And Other Intangible Assets                         158600000.0   155094000.0
Other Intangible Assets                                      158600000.0   155094000.0
Net PPE                                                       58506000.0    61266000.0
Accumulated Depreciation                                     -52478000.0   -22256000.0
Gross PPE                                                    110984000.0    83522000.0
Leases                                                        14655000.0    14663000.0
Construction In Progress                                       4960000.0     4638000.0
Other Properties                                              47173000.0    51394000.0
Machinery Furniture Equipment                                 39667000.0     8298000.0
Buildings And Improvements                                     4529000.0     4529000.0
Properties                                                           0.0           0.0
Current Assets                                               197968000.0   225816000.0
Other Current Assets                                           1079000.0     1069000.0
Restricted Cash                                                      NaN           NaN
Prepaid Assets                                                 7425000.0     6866000.0
Inventory                                                     10650000.0    12662000.0
Receivables                                                   37629000.0    46059000.0
Duefrom Related Parties Current                                 203000.0       76000.0
Accounts Receivable                                           37426000.0    45983000.0
Cash Cash Equivalents And Short Term Investments             141185000.0   159160000.0
Other Short Term Investments                                  55973000.0    59456000.0
Cash And Cash Equivalents                                     85212000.0    99704000.0
Free Cash Flow                                                -6233000.0     4053000.0
Repayment Of Debt                                             -1528000.0     -911000.0
Issuance Of Capital Stock                                     31907000.0    13894000.0
Capital Expenditure                                           -3050000.0    -6129000.0
Interest Paid Supplemental Data                                 609000.0     1600000.0
Income Tax Paid Supplemental Data                               257000.0      206000.0
End Cash Position                                             86202000.0   100694000.0
Beginning Cash Position                                       58881000.0    86202000.0
Changes In Cash                                               27321000.0    14492000.0
Financing Cash Flow                                           31023000.0    13718000.0
Cash Flow From Continuing Financing Activities                31023000.0    13718000.0
Proceeds From Stock Option Exercised                            644000.0      735000.0
Net Common Stock Issuance                                     31907000.0    13894000.0
Common Stock Issuance                                         31907000.0    13894000.0
Net Issuance Payments Of Debt                                 -1528000.0     -911000.0
Net Long Term Debt Issuance                                   -1528000.0     -911000.0
Long Term Debt Payments                                       -1528000.0     -911000.0
Investing Cash Flow                                            -519000.0    -9408000.0
Cash Flow From Continuing Investing Activities                 -519000.0    -9408000.0
Net Other Investing Changes                                          NaN           NaN
Net Investment Purchase And Sale                               2531000.0    -3279000.0
Sale Of Investment                                            16108000.0    13930000.0
Purchase Of Investment                                       -13577000.0   -17209000.0
Net Business Purchase And Sale                                       NaN           NaN
Purchase Of Business                                                 NaN           NaN
Net Intangibles Purchase And Sale                                    0.0           NaN
Purchase Of Intangibles                                              0.0           NaN
Net PPE Purchase And Sale                                     -3050000.0    -6129000.0
Purchase Of PPE                                               -3050000.0    -6129000.0
Operating Cash Flow                                           -3183000.0    10182000.0
Cash Flow From Continuing Operating Activities                -3183000.0    10182000.0
Change In Working Capital                                     -7761000.0     3351000.0
Change In Other Working Capital                                4918000.0     3116000.0
Change In Payables And Accrued Expense                       -12654000.0    10824000.0
Change In Inventory                                            -454000.0    -2032000.0
Change In Receivables                                           429000.0    -8557000.0
Changes In Account Receivables                                  429000.0    -8557000.0
Other Non Cash Items                                         -11262000.0     2152000.0
Stock Based Compensation                                       2845000.0     3983000.0
Provisionand Write Offof Assets                                  43000.0           NaN
Asset Impairment Charge                                              0.0           NaN
Deferred Tax                                                    -24000.0      447000.0
Deferred Income Tax                                             -24000.0      447000.0
Depreciation Amortization Depletion                            5558000.0     5678000.0
Depreciation And Amortization                                  5558000.0     5678000.0
Operating Gains Losses                                         1980000.0     1100000.0
Gain Loss On Investment Securities                             1980000.0     1100000.0
Net Income From Continuing Operations                          5438000.0    -6529000.0
Gross Margin                                                    0.692231      0.671251
ROE                                                             0.022174     -0.025365
Revenue YOY Growth                                                   NaN           NaN
EBITDA YOY Growth                                                    NaN           NaN

The company's P/E ratio transition is
            pe_ratio_transition
date                           
2024-10-31           -82.515154
2024-11-01           -78.525250
2024-11-04           -75.919196
2024-11-05           -75.616162
2024-11-06           -76.717169
2024-11-07           -75.939394
2024-11-08           -78.585862
2024-11-11           -74.131313
2024-11-12           -77.696968
2024-11-13           -79.272731
2024-11-14           -74.474751
2024-11-15           -69.121212
2024-11-18           -71.818180
2024-11-19           -71.757577
2024-11-20           -70.080805
2024-11-21           -72.797979
2024-11-22           -79.505050
2024-11-25           -81.272726
2024-11-26           -81.333330
2024-11-27           -80.232324
2024-11-29           -79.181818
2024-12-02           -78.020200
2024-12-03           -75.808084
2024-12-04           -80.434341
2024-12-05           -79.646463
2024-12-06           -77.979795
2024-12-09           -73.595960
2024-12-10           -72.666669
2024-12-11           -74.575759
2024-12-12           -72.494946
2024-12-13           -76.191920
2024-12-16           -81.313131
2024-12-17           -79.999997
2024-12-18           -77.707071
2024-12-19           -76.060609
2024-12-20           -78.181820
2024-12-23           -77.171719
2024-12-24           -78.181820
2024-12-26           -80.252522
2024-12-27           -78.838387
2024-12-30           -77.353537
2024-12-31           256.200002
2025-01-02           265.433324
2025-01-03           263.799998
2025-01-06           298.700002
2025-01-07           323.466670
2025-01-08           321.899999
2025-01-10           297.933324
2025-01-13           283.366674
2025-01-14           240.016658
2025-01-15           241.366679
2025-01-16           227.533340
2025-01-17           231.600011
2025-01-21           247.866669
2025-01-22           252.566655
2025-01-23           258.866679
2025-01-24           264.233322
2025-01-27           249.533335
2025-01-28           264.133326
2025-01-29           252.233327
2025-01-30           259.533335
2025-01-31           249.499995
2025-02-03           233.266678
2025-02-04           240.066655
2025-02-05           223.933334
2025-02-06           207.233327
2025-02-07           198.466670
2025-02-10           227.166672
2025-02-11           226.000010
2025-02-12           236.566671
2025-02-13           260.000000
2025-02-14           254.499995
2025-02-18           375.866674
2025-02-19           371.033325
2025-02-20           338.600006
2025-02-21           319.433339
2025-02-24           316.666667
2025-02-25           319.499995
2025-02-26           330.433324
2025-02-27           336.666667
2025-02-28           342.833328
2025-03-03           314.499995
2025-03-04           330.000000
2025-03-05           351.033325
2025-03-06           324.233322
2025-03-07           326.700007
2025-03-10           298.866679
2025-03-11           290.566661
2025-03-12           306.933339
2025-03-13           297.733332
2025-03-14           328.233337
2025-03-17           314.866664
2025-03-18           302.633336
2025-03-19           324.800008
2025-03-20           322.366664
2025-03-21           347.966665
2025-03-24           343.966675
2025-03-25           335.299988
2025-03-26           321.466675
2025-03-27           314.466654
2025-03-28           307.333323
2025-03-31            97.324179
2025-04-01            92.956040
2025-04-02            93.263739
2025-04-03            88.032968
2025-04-04            87.934062
2025-04-07            93.153842
2025-04-08            94.461537
2025-04-09           106.912089
2025-04-10           101.780223
2025-04-11           106.186810
2025-04-14           111.032968
2025-04-15           112.329672
2025-04-16           107.999999
2025-04-17           104.912089
2025-04-21           100.043957
2025-04-22           106.472527
2025-04-23           116.142860
2025-04-24           120.208791
2025-04-25           121.989013
2025-04-28           123.615382
2025-04-29           128.538463

The company's P/S ratio transition is
                close
date                 
2024-12-31  22.515178
2025-01-02  23.326614
2025-01-03  23.183076
2025-01-06  26.250132
2025-01-07  28.426658
2025-01-08  28.288977
2025-01-10  26.182755
2025-01-13  24.902620
2025-01-14  21.092966
2025-01-15  21.211607
2025-01-16  19.995916
2025-01-17  20.353300
2025-01-21  21.782835
2025-01-22  22.195875
2025-01-23  22.749529
2025-01-24  23.221157
2025-01-27  21.929303
2025-01-28  23.212369
2025-01-29  22.166582
2025-01-30  22.808116
2025-01-31  21.926373
2025-02-03  20.499769
2025-02-04  21.097360
2025-02-05  19.679543
2025-02-06  18.211925
2025-02-07  17.441501
2025-02-10  19.963693
2025-02-11  19.861165
2025-02-12  20.789777
2025-02-13  22.849127
2025-02-14  22.365780
2025-02-18  33.031636
2025-02-19  32.606875
2025-02-20  29.756594
2025-02-21  28.072204
2025-02-24  27.829065
2025-02-25  28.078061
2025-02-26  29.038896
2025-02-27  29.586690
2025-02-28  30.128624
2025-03-03  27.638655
2025-03-04  29.000815
2025-03-05  30.849250
2025-03-06  28.494032
2025-03-07  28.710808
2025-03-10  26.264780
2025-03-11  25.535364
2025-03-12  26.973688
2025-03-13  26.165180
2025-03-14  28.845559
2025-03-17  27.670878
2025-03-18  26.595798
2025-03-19  28.543833
2025-03-20  28.329988
2025-03-21  30.579748
2025-03-24  30.228224
2025-03-25  29.466585
2025-03-26  28.250896
2025-03-27  27.635725
2025-03-28  27.008839
2025-03-31  29.006542
2025-04-01  27.704660
2025-04-02  27.796367
2025-04-03  26.237386
2025-04-04  26.207908
2025-04-07  27.763614
2025-04-08  28.153360
2025-04-09  31.864128
2025-04-10  30.334624
2025-04-11  31.647965
2025-04-14  33.092316
2025-04-15  33.478786
2025-04-16  32.188369
2025-04-17  31.268047
2025-04-21  29.817146
2025-04-22  31.733120
2025-04-23  34.615271
2025-04-24  35.827083
2025-04-25  36.357661
2025-04-28  36.842385
2025-04-29  38.309662
